Quince Therapeutics, Inc. (QNCX)
NASDAQ: QNCX · Real-Time Price · USD
0.107
+0.004 (4.11%)
At close: Mar 9, 2026, 4:00 PM EDT
0.105
-0.001 (-1.22%)
After-hours: Mar 9, 2026, 7:59 PM EDT
Quince Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Mar '26 Mar 9, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Market Capitalization | 6 | 82 | 45 | 23 | 377 | 819 | |
| Market Cap Growth | -90.37% | 82.80% | 95.46% | -93.89% | -53.99% | -45.64% | |
| Enterprise Value | -2 | 50 | -38 | -71 | 264 | 682 | |
| Last Close Price | 0.11 | 1.87 | 1.05 | 0.64 | 12.62 | 27.78 | |
| PB Ratio | 5.48 | 2.73 | 0.53 | 0.23 | 3.18 | 4.76 | |
| P/TBV Ratio | 9.95 | - | 11.89 | 0.24 | 3.18 | 4.76 | |
| Debt / Equity Ratio | 16.99 | 0.49 | 0.16 | 0.01 | 0.01 | 0.00 | |
| Net Debt / Equity Ratio | -7.83 | -0.86 | -0.72 | -0.89 | -0.89 | -0.77 | |
| Net Debt / EBITDA Ratio | 0.20 | 0.78 | 2.52 | 1.80 | 1.17 | 1.70 | |
| Net Debt / FCF Ratio | 0.21 | 0.81 | 3.32 | 2.03 | 1.67 | 2.62 | |
| Quick Ratio | 1.05 | 5.73 | 7.95 | 29.71 | 7.59 | 7.87 | |
| Current Ratio | 1.12 | 6.05 | 8.09 | 30.55 | 7.85 | 8.11 | |
| Return on Equity (ROE) | -247.78% | -98.63% | -33.81% | -47.14% | -61.85% | -53.42% | |
| Return on Assets (ROA) | -22.10% | -14.90% | -11.33% | -26.40% | -34.99% | -31.42% | |
| Return on Capital Employed (ROCE) | -49.90% | -31.40% | -15.60% | -49.70% | -75.90% | -45.70% | |
| Earnings Yield | -960.85% | -69.06% | -69.73% | -224.32% | -23.86% | -9.38% | |
| FCF Yield | -657.28% | -39.09% | -40.99% | -191.80% | -16.74% | -6.21% | |
| Buyback Yield / Dilution | -10.61% | -16.18% | -11.17% | -12.71% | -1.86% | -53.30% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.